U.S. federal trademark · Serial No. 79301893 · Reg. No. 6641505
Downloadable computer software for digitizing records, scheduling of all critical manufacturing criteria, including inbound starting material, availability and assignment of manufacturing operatives, availability and assignment of manufacturing equipment, and availability and assignment of GMP cleanroom, and quality approval of the manufacturing processes and specification of the drug product in the field of cell and gene therapy; recorded and downloadable computer software platforms for autologous medicines for digitizing records, scheduling of all critical manufacturing criteria, including inbound starting material, availability and assignment of manufacturing operatives, availability and assignment of manufacturing equipment, and availability and assignment of GMP cleanroom and quality approval of the manufacturing processes and specification of the drug product; downloadable computer software that enables users to digitise, upload and automate information relating to cell and gene therapy
Platform as a service (PAAS) featuring computer software platforms for autologous medicines for digitizing records, scheduling of all critical manufacturing criteria, including inbound starting material, availability and assignment of manufacturing operatives, availability and assignment of manufacturing equipment, and availability and assignment of GMP cleanroom and quality approval of the manufacturing processes and specification of the drug product in the field of cell and gene therapy; software as a service (SAAS) services featuring software for autologous medicines for digitizing and downloading records, scheduling of all critical manufacturing criteria, including inbound starting material, availability and assignment of manufacturing operatives, availability and assignment of manufacturing equipment, and availability and assignment of GMP cleanroom, and quality approval of the manufacturing processes and specification of the drug product in the field of cell and gene therapy; providing software as a service (SAAS) services featuring software that enables users to digitise, upload, download, and automate information relating to gene and cell therapy
Data management services in relation to autologous medicines, namely, electronic data collection and data submission services for business purposes in the field of autologous medicines; compilation of information relating to gene and cell therapy into computer databases; data hub services, namely, data processing services and management and compilation of computerised databases; systemization of information relating to autologous medicines into computer databases
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.